
Agnieszka Boesen
Examiner (ID: 10144, Phone: (571)272-8035 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1672, 1648 |
| Total Applications | 1050 |
| Issued Applications | 614 |
| Pending Applications | 117 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5112474
[patent_doc_number] => 20070196389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'VIRAL GENE PRODUCTS AND METHODS FOR VACCINATION TO PREVENT VIRAL ASSOCIATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 11/561363
[patent_app_country] => US
[patent_app_date] => 2006-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13169
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20070196389.pdf
[firstpage_image] =>[orig_patent_app_number] => 11561363
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/561363 | VIRAL GENE PRODUCTS AND METHODS FOR VACCINATION TO PREVENT VIRAL ASSOCIATED DISEASES | Nov 16, 2006 | Abandoned |
Array
(
[id] => 4886358
[patent_doc_number] => 20080260690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Interferon in Influenza'
[patent_app_type] => utility
[patent_app_number] => 12/091985
[patent_app_country] => US
[patent_app_date] => 2006-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6766
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20080260690.pdf
[firstpage_image] =>[orig_patent_app_number] => 12091985
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/091985 | Interferon in Influenza | Nov 15, 2006 | Abandoned |
Array
(
[id] => 5446127
[patent_doc_number] => 20090047353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'CHANGING TH1/TH2 BALANCE IN SPLIT INFLUENZA VACCINES WITH ADJUVANTS'
[patent_app_type] => utility
[patent_app_number] => 12/092146
[patent_app_country] => US
[patent_app_date] => 2006-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14084
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20090047353.pdf
[firstpage_image] =>[orig_patent_app_number] => 12092146
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/092146 | CHANGING TH1/TH2 BALANCE IN SPLIT INFLUENZA VACCINES WITH ADJUVANTS | Nov 5, 2006 | Abandoned |
Array
(
[id] => 5095522
[patent_doc_number] => 20070117131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process'
[patent_app_type] => utility
[patent_app_number] => 11/592336
[patent_app_country] => US
[patent_app_date] => 2006-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4760
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20070117131.pdf
[firstpage_image] =>[orig_patent_app_number] => 11592336
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/592336 | Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process | Nov 2, 2006 | Abandoned |
Array
(
[id] => 5188014
[patent_doc_number] => 20070166322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'ADJUVANT VIRAL PARTICLE'
[patent_app_type] => utility
[patent_app_number] => 11/556678
[patent_app_country] => US
[patent_app_date] => 2006-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 27694
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20070166322.pdf
[firstpage_image] =>[orig_patent_app_number] => 11556678
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/556678 | Vaccines and immunopotentiating compositions and methods for making and using them | Nov 2, 2006 | Issued |
Array
(
[id] => 6125572
[patent_doc_number] => 20110086065
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2011-04-14
[patent_title] => 'Lentival Vector-Based Vaccine'
[patent_app_type] => utility
[patent_app_number] => 12/083532
[patent_app_country] => US
[patent_app_date] => 2006-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13924
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0086/20110086065.pdf
[firstpage_image] =>[orig_patent_app_number] => 12083532
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/083532 | Lentiviral vector-based vaccine | Oct 16, 2006 | Issued |
Array
(
[id] => 6125572
[patent_doc_number] => 20110086065
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2011-04-14
[patent_title] => 'Lentival Vector-Based Vaccine'
[patent_app_type] => utility
[patent_app_number] => 12/083532
[patent_app_country] => US
[patent_app_date] => 2006-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13924
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0086/20110086065.pdf
[firstpage_image] =>[orig_patent_app_number] => 12083532
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/083532 | Lentiviral vector-based vaccine | Oct 16, 2006 | Issued |
Array
(
[id] => 5547013
[patent_doc_number] => 20090156890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'PEROXISOME PROLIFERATOR-ACTIVATOR RECEPTOR DELTA (PPARDELTA) AND THE DEVELOPMENT OF PREIMPLANTATION EMBRYOS'
[patent_app_type] => utility
[patent_app_number] => 12/090060
[patent_app_country] => US
[patent_app_date] => 2006-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13302
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20090156890.pdf
[firstpage_image] =>[orig_patent_app_number] => 12090060
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/090060 | Peroxisome proliferator-activator receptor δ (PPARδ) and the development of preimplantation embryos | Oct 11, 2006 | Issued |
Array
(
[id] => 5315909
[patent_doc_number] => 20090280507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'METHOD FOR MEASUREMENT OF SARS VIRUS NUCLEOCAPSID PROTEIN, REAGENT KIT FOR THE MEASUREMENT, TEST DEVICE, MONOCLONAL ANTIBODY DIRECTED AGAINST SARS VIRUS NUCLEOCAPSID PROTEIN, AND HYBRIDOMA CAPABLE OF PRODUCING THE MONOCLONAL ANTIBODY'
[patent_app_type] => utility
[patent_app_number] => 12/090055
[patent_app_country] => US
[patent_app_date] => 2006-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11810
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20090280507.pdf
[firstpage_image] =>[orig_patent_app_number] => 12090055
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/090055 | METHOD FOR MEASUREMENT OF SARS VIRUS NUCLEOCAPSID PROTEIN, REAGENT KIT FOR THE MEASUREMENT, TEST DEVICE, MONOCLONAL ANTIBODY DIRECTED AGAINST SARS VIRUS NUCLEOCAPSID PROTEIN, AND HYBRIDOMA CAPABLE OF PRODUCING THE MONOCLONAL ANTIBODY | Oct 10, 2006 | Abandoned |
Array
(
[id] => 5302941
[patent_doc_number] => 20090297593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment'
[patent_app_type] => utility
[patent_app_number] => 12/083209
[patent_app_country] => US
[patent_app_date] => 2006-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 15272
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20090297593.pdf
[firstpage_image] =>[orig_patent_app_number] => 12083209
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/083209 | Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment | Oct 4, 2006 | Abandoned |
Array
(
[id] => 5204502
[patent_doc_number] => 20070025982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'DNA vaccines encoding antigen linked to a domain that binds CD40'
[patent_app_type] => utility
[patent_app_number] => 11/542423
[patent_app_country] => US
[patent_app_date] => 2006-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6987
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20070025982.pdf
[firstpage_image] =>[orig_patent_app_number] => 11542423
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/542423 | DNA vaccines encoding antigen linked to a domain that binds CD40 | Oct 2, 2006 | Abandoned |
Array
(
[id] => 5252778
[patent_doc_number] => 20070134234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Immunomodulatory compositions and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/541449
[patent_app_country] => US
[patent_app_date] => 2006-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 61823
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134234.pdf
[firstpage_image] =>[orig_patent_app_number] => 11541449
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/541449 | Immunomodulatory compositions and uses therefor | Sep 28, 2006 | Abandoned |
Array
(
[id] => 5172606
[patent_doc_number] => 20070073039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Peptides that inhibit viral infections'
[patent_app_type] => utility
[patent_app_number] => 11/541488
[patent_app_country] => US
[patent_app_date] => 2006-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 47478
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20070073039.pdf
[firstpage_image] =>[orig_patent_app_number] => 11541488
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/541488 | Peptides that inhibit viral infections | Sep 28, 2006 | Abandoned |
Array
(
[id] => 8188892
[patent_doc_number] => 08183044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-22
[patent_title] => 'Recombinant human hepatitis C virus-like particle and method for producing the same'
[patent_app_type] => utility
[patent_app_number] => 11/992646
[patent_app_country] => US
[patent_app_date] => 2006-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15117
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/183/08183044.pdf
[firstpage_image] =>[orig_patent_app_number] => 11992646
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/992646 | Recombinant human hepatitis C virus-like particle and method for producing the same | Sep 28, 2006 | Issued |
Array
(
[id] => 10082498
[patent_doc_number] => 09119828
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-01
[patent_title] => 'Antibodies with simultaneous subsite specificities to protein and lipid epitopes'
[patent_app_type] => utility
[patent_app_number] => 11/525574
[patent_app_country] => US
[patent_app_date] => 2006-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 12575
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11525574
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/525574 | Antibodies with simultaneous subsite specificities to protein and lipid epitopes | Sep 21, 2006 | Issued |
Array
(
[id] => 5004979
[patent_doc_number] => 20070202549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Assessing risk of cerebrovascular thrombosis by measuring C4d on platelets'
[patent_app_type] => utility
[patent_app_number] => 11/521643
[patent_app_country] => US
[patent_app_date] => 2006-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4561
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20070202549.pdf
[firstpage_image] =>[orig_patent_app_number] => 11521643
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/521643 | Assessing risk of cerebrovascular thrombosis by measuring C4d on platelets | Sep 13, 2006 | Abandoned |
Array
(
[id] => 5148677
[patent_doc_number] => 20070048736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'HEPATITIS'
[patent_app_type] => utility
[patent_app_number] => 11/466831
[patent_app_country] => US
[patent_app_date] => 2006-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7401
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048736.pdf
[firstpage_image] =>[orig_patent_app_number] => 11466831
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/466831 | HEPATITIS | Aug 23, 2006 | Abandoned |
Array
(
[id] => 4791681
[patent_doc_number] => 20080292654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Human Bocavirus and Methods of Diagnosis and Treatment'
[patent_app_type] => utility
[patent_app_number] => 12/094135
[patent_app_country] => US
[patent_app_date] => 2006-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9570
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20080292654.pdf
[firstpage_image] =>[orig_patent_app_number] => 12094135
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/094135 | Human Bocavirus and methods of diagnosis and treatment | Aug 15, 2006 | Issued |
Array
(
[id] => 5409597
[patent_doc_number] => 20090123495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Immune Response Inducing Preparations'
[patent_app_type] => utility
[patent_app_number] => 12/063388
[patent_app_country] => US
[patent_app_date] => 2006-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11446
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20090123495.pdf
[firstpage_image] =>[orig_patent_app_number] => 12063388
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/063388 | Immune Response Inducing Preparations | Aug 7, 2006 | Abandoned |
Array
(
[id] => 5182587
[patent_doc_number] => 20070053933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'IL28 and IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 11/458945
[patent_app_country] => US
[patent_app_date] => 2006-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55354
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20070053933.pdf
[firstpage_image] =>[orig_patent_app_number] => 11458945
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/458945 | IL28 and IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME | Jul 19, 2006 | Abandoned |